Parkinson disease is a progressive neurodegenerative disorder affecting the dopaminergic neurons of the basal ganglia, affecting approximately 1% of individuals over the age of 65. The travel health challenges of patients with Parkinson disease have not been adequately addressed in the medical literature. This perspective article discusses the barriers to healthy travel in this vulnerable population and considers mitigating measures. It focuses on difficulties with mobility, cognitive impairment, chronic medications, and medical devices.
Shabu,A. , Flaherty,E. , Browne,P. and Flaherty,G. (2022). Health advice for international travelers living with Parkinson disease. International Journal of Travel Medicine and Global Health, 10(4), 155-158. doi: 10.30491/ijtmgh.2022.161914
MLA
Shabu,A. , , Flaherty,E. , , Browne,P. , and Flaherty,G. . "Health advice for international travelers living with Parkinson disease", International Journal of Travel Medicine and Global Health, 10, 4, 2022, 155-158. doi: 10.30491/ijtmgh.2022.161914
HARVARD
Shabu A., Flaherty E., Browne P., Flaherty G. (2022). 'Health advice for international travelers living with Parkinson disease', International Journal of Travel Medicine and Global Health, 10(4), pp. 155-158. doi: 10.30491/ijtmgh.2022.161914
CHICAGO
A. Shabu, E. Flaherty, P. Browne and G. Flaherty, "Health advice for international travelers living with Parkinson disease," International Journal of Travel Medicine and Global Health, 10 4 (2022): 155-158, doi: 10.30491/ijtmgh.2022.161914
VANCOUVER
Shabu A., Flaherty E., Browne P., Flaherty G. Health advice for international travelers living with Parkinson disease. Int J Travel Med Glob Health, 2022; 10(4): 155-158. doi: 10.30491/ijtmgh.2022.161914
